Warner Chilcott global restructuring entails elimination of 87 local jobs
Ireland-based specialty pharmaceutical company Warner Chilcott on Monday announced plans to restructure its European operations and finalize the conversion of its Manatí plant into a warehouse, supposing the elimination of 87 jobs effective mid-May.
The “repurposing” of the Manatí plant will cost Warner Chilcott some $33 million, of which $7 million will go toward employee severance packages, the company said in a statement.
“Going forward, this [Manatí] facility will primarily serve as a warehouse and distribution service center,” the company said in reference to the operation that Warner Chilcott acquired from Procter & Gamble in 2009.
Warner Chilcott will retain its manufacturing and research operation in Fajardo. The company produces women’s health-care, gastroenterology, dermatology and urology products for the North American and Western European pharmaceuticals markets.
Its European restructuring will affect operations in Belgium, the Netherlands, France, Germany, Italy, Spain, Switzerland, and the United Kingdom, leaving its Ireland headquarters intact.
